124 - Faster Shin Splints Treatment with Ben Lindsay from SOLUSHIN

Ben Lindsay is a multi-award winning biomedical engineer and co-inventor of the SOLUSHIN - The Faster Shin Splint Treatment medical device. It was developed to help athletes get back to running, pain-free, faster than ever before. 

Before pursuing a career in biomedical engineering, Ben was a national medalist in the 50m Butterfly and due to cross-training, a sufferer of medial tibial stress syndrome. 

On this episode we discuss:

  • The development and research that took place to male SOLUSHIN a reality.
  • Load management & strengthening for shin splints.
  • How it improves ankle ROM.
  • Solushin gives short-term pain relief.
  • What they learnt from asking 500+ runners what they would pay to have their shin splints fixed.  
  • Helping researchers and students commercialise products.

You can order SOLUSHIN directly from their website www.solushin.com, and if you want to contact Ben, you can email him at email/ben)(solushin.com

If you're interested in watching the video of this particular episode, you can visit my YOUTUBE Channel, Tyson Franklin.  

If you have any questions about this episode, please send me an email at email/tf)(tysonfranklin.com.

My Next Event - Podiatry Marketing Workshop 2021 

Over the past thirty-plus years, I have opened, sold, relocate and taken over more than 20 podiatry businesses, so when it comes to marketing a podiatry business successfully, I know what works, and what's a waste of time and money.

During this 4-hour workshop, I will explain, step-by-step, how I took a small podiatry business with one consultation room from $0 to $402,000 in the first 12-months. 

With this information, you will have a competitive advantage over your competitors. 

For more detail, please visit my EVENTS PAGE.

If you want to learn more about my next 12-Week Podiatry Business Reboot or join the Podiatry Business Owners Club on Facebook, please follow the links.       


Join The Discussion

Add Your Comments

(Required, not publicised)